Jagannathan Jay, Smith Rene, DeVroom Hetty L, Vortmeyer Alexander O, Stratakis Constantine A, Nieman Lynnette K, Oldfield Edward H
Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
J Neurosurg. 2009 Sep;111(3):531-9. doi: 10.3171/2008.8.JNS08339.
Many patients with Cushing disease still have active or recurrent disease after pituitary surgery. The histological pseudocapsule of a pituitary adenoma is a layer of compressed normal anterior lobe that surrounds the adenoma and can be used during surgery to identify and guide removal of the tumor. In this study the authors examined the results of using the pseudocapsule as a surgical capsule in the resection of adenomas in patients with Cushing disease.
The authors reviewed a prospective database of data obtained in patients with Cushing disease who underwent surgery. The analysis included all cases in which a lesion was identified during surgery and in which the lesion was believed to be confined to the pituitary gland in patients with Cushing disease between January 1990 and March 2007. Since the objective was to determine the success of using the pseudocapsule as a surgical capsule, patients with invasive tumors and patients in whom no lesion was identified during surgery-challenging cases for surgical success-were excluded from analysis.
In 261 patients an encapsulated adenoma was identified at surgery. Tumor was visible on MR imaging in 135 patients (52%); in 126 patients (48%) MR imaging detected no tumor. The range of tumor size overlapped considerably in the groups with positive and negative MR imaging results, indicating that in addition to size other features of the adenoma influence the results of MR imaging. In 252 patients hypercortisolism resolved after the first operation, whereas in 9 patients (3 with positive MR imaging and 6 with negative MR imaging) early reoperation was required. Hypercortisolism resolved in all 261 patients (256 with hypocortisolism and 5 with eucortisolism) before hospital discharge. Forty-six patients (18%) had postoperative electrolyte abnormalities (30 with hyponatremia and 16 with diabetes insipidus), but only 2 patients required treatment at discharge. The mean clinical follow-up duration was 84 months (range 12-215 months). Six patients (2%) had recurrence of hypercortisolism, all of whom were treated successfully with reoperation.
Because of their small size, adenomas can be challenging to identify in patients with Cushing disease. Use of the histological pseudocapsule of an adenoma allows accurate identification of the tumor and helps guide its complete excision. With this approach the overall remission rate is high and the rate of complications is low.
许多库欣病患者在垂体手术后仍有疾病活动或复发。垂体腺瘤的组织学假包膜是一层围绕腺瘤的受压正常前叶组织,手术中可用于识别和指导肿瘤切除。在本研究中,作者探讨了在库欣病患者腺瘤切除术中将假包膜用作手术包膜的效果。
作者回顾了库欣病手术患者的前瞻性数据库。分析纳入了1990年1月至2007年3月期间库欣病患者中所有手术中发现病变且认为病变局限于垂体的病例。由于目的是确定将假包膜用作手术包膜的成功率,因此将侵袭性肿瘤患者和手术中未发现病变的患者(手术成功的挑战性病例)排除在分析之外。
261例患者手术中发现有包膜的腺瘤。135例患者(52%)的肿瘤在磁共振成像(MR)上可见;126例患者(48%)MR未检测到肿瘤。MR成像结果为阳性和阴性的两组患者肿瘤大小范围有相当大的重叠,这表明除大小外,腺瘤的其他特征也会影响MR成像结果。252例患者首次手术后皮质醇增多症缓解,而9例患者(3例MR成像阳性,6例MR成像阴性)需要早期再次手术。所有261例患者(256例出现皮质醇减少,5例皮质醇正常)在出院前皮质醇增多症均得到缓解。46例患者(18%)术后出现电解质异常(30例低钠血症,16例尿崩症),但出院时仅2例患者需要治疗。平均临床随访时间为84个月(范围12 - 215个月)。6例患者(2%)出现皮质醇增多症复发,均通过再次手术成功治疗。
由于腺瘤体积小,库欣病患者的腺瘤识别具有挑战性。使用腺瘤的组织学假包膜可准确识别肿瘤并有助于指导其完整切除。采用这种方法总体缓解率高且并发症发生率低。